HomeOLMA • NASDAQ
add
Olema Pharmaceuticals Inc
Previous close
$11.48
Day range
$10.10 - $12.26
Year range
$8.51 - $17.22
Market cap
578.39M USD
Avg Volume
367.45K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 37.62M | 61.17% |
Net income | -34.56M | -60.71% |
Net profit margin | — | — |
Earnings per share | -0.60 | -25.00% |
EBITDA | -37.53M | -61.39% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 214.76M | -22.44% |
Total assets | 230.17M | -21.39% |
Total liabilities | 31.26M | 76.97% |
Total equity | 198.91M | — |
Shares outstanding | 57.26M | — |
Price to book | 3.31 | — |
Return on assets | -38.81% | — |
Return on capital | -43.89% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -34.56M | -60.71% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2006
Headquarters
Website
Employees
87
